Norgine is a leading European specialist pharmaceutical company with 110 years' heritage. Norgine has a presence in all major European markets and employs over 1,000 people. Norgine operates a well-...
Norgine is a leading European specialist pharmaceutical company with 110 years' heritage. Norgine has a presence in all major European markets and employs over 1,000 people. Norgine operates a well-established European infrastructure to develop, manufacture and commercialise products. Norgine specialises in gastroenterology, hepatology , cancer and supportive care therapy areas. What sets Norgine apart from other companies is its flexible and agile approach to partnering and collaboration. Norgine is able to integrate new products quickly for the benefit of healthcare systems and patients in Europe, Australia and New Zealand. Norgine is headquartered in the Netherlands with global operations in Amsterdam and in Harefield, UK. Norgine owns a R&D site in Hengoed, Wales and two manufacturing sites in Hengoed, Wales and Dreux, France. In 2012, Norgine established a complementary business Norgine Ventures, supporting innovative healthcare companies through the provision of debt-like financing in Europe and the US. For more information, please visit www.norgineventures.com.